FDA Tells Stem Cell Cos. Regulatory Eyes Fixed On Them

The U.S. Food and Drug Administration on Thursday said it has sent a warning letter to Genetech Inc. for marketing “dangerous unapproved stem cell products,” as well as to other clinics believed to be offering stem cell treatments to remind them that regulators are closely watching the safety of the emerging science.